ArticleOphthalmology science2021

TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration.

Arshad M Khanani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.